Kenya Enhanced Mentor Mother ProgrAm (EMMA)
NCT02848235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 363
Last updated 2023-06-08
Summary
Kenya recently adopted new treatment guidelines for pregnant women with HIV, which calls for all women to initiate triple-drug antiretroviral therapy (ART) at or soon after their first visit for antenatal care. As part of this new standard of care to prevent mother to child transmission of HIV (PMTCT), Kenya also established the Kenya Mentor Mother Program (KMMP) in 2012 to provide guidance for standardizing peer education and psychosocial support services within the national PMTCT program. This new standard of care (life-long ART and the KMMP) will only yield significant improvements in preventing mother to child transmission if women accept the triple-drug treatment during pregnancy and adhere to visit schedules so that they receive uninterrupted supplies of their medications during pregnancy through at least the cessation of breastfeeding. The primary objectives of this study are: (1) to evaluate implementation of the new guidelines in Kenya under actual, real-world conditions in major maternal and child health clinics in the southern Rift Valley region of Kenya; and (2) to evaluate, also under routine program conditions, the benefits of an innovative intervention package designed to improve implementation of the new treatment guidelines. The intervention uses the existing Mentor Mothers, who already are part of the PMTCT program staff at clinics. At the end of each clinic visit, the Mentor Mother will review with patients their treatment plan and schedule their next visit. The Mentor Mother will also offer, at each encounter, to send a text message reminder to the patient for their next clinic visit and offer to set up an automatic reminder directly on the patient's cell phone. The intervention strategy was developed in close collaboration with local health facility and PMTCT program staff based on their prior and on-going experience providing PMTCT services in the region, and this strategy has the potential to dramatically improve PMTCT service delivery and support global goals to eliminate mother to child transmission.
The study is taking place in 12 clinics in the south-rift valley region of Kenya. A total of 360 patients will be enrolled into the study (approximately 30 at each clinic). The investigators are enrolling patients to receive their permission to look at information recorded in their medical records. All patients eligible for the study, who provide written consent, will be included in the study until the target number of 360 is obtained. After consenting, the study will have no further contact with patients. Because the study only reviews information in medical files that clinics already collect as part of routine care, risks to patients are minimal. The only possible risk is the accidental disclosure of HIV status, but the study is designed to minimize such a risk. There are no direct benefits to study participants, as the study is designed to understand existing adherence to PMTCT care and treatment and to improve such adherence. The study is expected to start in 2016 and end in 2019.
Conditions
- HIV
- Pregnancy
Interventions
- OTHER
-
Standard of Care + EMMA
Mother Mentors will provide enhanced care, above that of the standard of care, to include clinic visit exit discussions, visit reminder messages, and patient follow-up in the event that a clinic visit is missed.
Sponsors & Collaborators
-
Kenya Medical Research Institute
collaborator OTHER -
United States President's Emergency Plan for AIDS Relief
collaborator FED -
Kenya Ministry of Health
collaborator OTHER_GOV -
Boston University
collaborator OTHER -
Henry M. Jackson Foundation for the Advancement of Military Medicine
lead OTHER
Principal Investigators
-
Fredrick Sawe, MBChB, MMED · KEMRI/WRP
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-18
- Primary Completion
- 2019-09-30
- Completion
- 2019-09-30
Countries
- Kenya
Study Locations
More Related Trials
-
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
NCT00936195 ·Status: WITHDRAWN ·Phase: PHASE3
-
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 ·Status: RECRUITING ·Phase: PHASE4
-
The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV
NCT02295800 ·Status: COMPLETED
-
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
NCT02371265 ·Status: COMPLETED ·Phase: NA
-
mWACh-PrEP: A SMS-based Support Intervention to Enhance PrEP Adherence During Pregnancy and Breastfeeding
NCT04472884 ·Status: UNKNOWN ·Phase: NA
-
PrEP Implementation for Mothers in Antenatal Care
NCT03070600 ·Status: COMPLETED ·Phase: PHASE4
-
Mother Infant Retention for Health: MIR4Health
NCT01962220 ·Status: COMPLETED ·Phase: NA
-
PrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency
NCT04712994 ·Status: COMPLETED ·Phase: NA
-
The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
NCT01936753 ·Status: COMPLETED ·Phase: NA
-
A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya
NCT06842732 ·Status: RECRUITING ·Phase: NA
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
NCT01645865 ·Status: COMPLETED
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV
NCT01433185 ·Status: COMPLETED ·Phase: NA
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Home-based Partner Education and Testing (HOPE) Study
NCT01784783 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
NCT01088516 ·Status: COMPLETED ·Phase: PHASE4
-
Piloting At-birth Point of Care HIV Testing Strategies in Kenya
NCT03435887 ·Status: COMPLETED ·Phase: NA
-
Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP
NCT00204308 ·Status: COMPLETED ·Phase: PHASE2
-
HIV Exposure in Utero and Metabolic Disease Risk in HIV-Negative Young Adults
NCT04132830 ·Status: COMPLETED
-
Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA
NCT03153709 ·Status: COMPLETED
-
Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
NCT02249962 ·Status: COMPLETED